Pexidartinib (PLX-3397) is a capsule containing a small-molecule receptor tyrosine kinase (RTK) inhibitor targeting KIT, CSF1R, and FLT3, with potential antineoplastic activity.
Molecular Weight:
417.81
Purity:
98.00%
CAS Number:
[1029044-16-3]
Formula:
C20H15ClF3N5
Target:
FLT|||Apoptosis|||c-Fms|||c-Kit|||CSF-1R
T2115
* VAT and and shipping costs not included. Errors and price changes excepted